Request Covid 19 Impact
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
MarketResearch.Biz delivers in-depth insights in its upcoming report titled “Global Microbiome Therapeutics Market: Trends, Applications, Analysis, Growth, and Forecast 2018 to 2027”. The global microbiome therapeutics market is estimated to register a CAGR of X.X% in terms of value during forecast period 2018–2027. The report offers in-depth insights, revenue details, and other vital information regarding the global microbiome therapeutics market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027. The report offers insightful and detailed information regarding the various key players operating in the global microbiome therapeutics market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global microbiome therapeutics market report has been segmented on the basis of product type, distribution channel, application area, and region.
The human microbiome refers to the group of microorganisms such as bacteria, archaea, and fungi that reside on skin layers, in saliva, conjunctiva, oral mucosa and the gastrointestinal tract (GIT). These microorganisms perform tasks which are beneficial for the human host in maintaining health. In microbiome therapeutics: probiotics, prebiotics and synbiotics play a vital role in diagnosis, prevention, and treatment of various disease conditions. Probiotics are microorganisms such as bacteria, yeasts that provide health benefits when consumed. Prebiotics are non-digestible carbohydrate that helps in growth of microbes that are present in the body. Furthermore, combination of probiotics and prebiotics are referred to as synbiotics. The most beneficial factor for microbiome therapeutics is that they do not cause any side effects unlike the drug molecules as they are already present within the body. As a result, they are helpful in treating various disease indications such as Crohn's disease and irritable bowel syndrome conditions that do not have any proper treatment.
Factors driving growth of the global microbiome therapeutics market are rise in digestive disorders, and increasing incidence of drug-related side effects. In addition, high amount of funding for biological drug development studies and collaboration between major players in the global microbiome market are major factors contributing to growth of global microbiome therapeutics market.
However, high cost of equipment and machinery, and complex processes to develop and extract the bacteria in the laboratory are restraining growth of the global microbiome therapeutics market. In addition, factors such as heat sensitiveness displayed by the microbiomes, and lack of proper regulations are hindering growth of the global microbiome therapeutics market.
North America market is expected to dominate the global microbiome therapeutics market in terms of revenue share, owing to rise in consumption in of dietary supplements. Moreover, highly established research facility for the development of novel therapeutics, presence of health-conscious population, and rising healthcare expenditure are the major factors for dominance of the region. Europe market is expected to account for second largest market share contribution to the global microbiome therapeutics market, followed by Asia Pacific market. Markets in emerging economies in the Asia Pacific such as Japan and China are anticipated to expand at the highest CAGR of X.X% over the forecast period, due to high amount of biological research initiatives in national institutes, increasing economic stability, and growing awareness among physicians regarding novel therapeutics.
Global Microbiome Therapeutics Market Segmentation:
Global microbiome therapeutics market segmentation, by product type:
Global microbiome therapeutics market segmentation, by distribution channel:
- Hospital Pharmacies
- Drug stores
- Retail Pharmacies
- Super and Hypermarkets
- E-commerce stores
Global microbiome therapeutics market segmentation, by application area:
- Digestive Health
- Respiratory Health
- Oral Health
- Immune conditions
Global microbiome therapeutics market segmentation, by region:
- North America
- Asia Pacific
- Middle East & Africa
- Latin America
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn
- Johnson and Johnson
- Vedanta Biosciences
- AbbVie Inc.
- Sigma-Tau Pharmaceuticals
Request for TOC
Don't just take our word. We are trusted by these great companies!